European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS

Children’s Liver Tumour European Research Network

Cel

Liver cancer in the paediatric population is rare with an incidence approximately 1-1.5 per million population. The commonest tumour seen in the childhood population is hepatoblastoma (HB), usually seen in young children and infants. Much rarer (about 10% of paediatric liver cancers) is hepatocellular carcinoma (HCC), usually seen in the teenage population and sometimes associated with underlying cirrhotic liver diseases. The ChiLTERN project relates to topic PHC 18 ‘establishing effectiveness of health care interventions in the paediatric population’. The ChiLTERN project builds on a unique opportunity to undertake a comprehensive research programme linked to an ambitious global partnership which will see the single largest clinical trial (the Paediatric Hepatic International Tumour Trial - PHITT) ever undertaken in this population of patients, with several randomised questions in six subgroups of patients. ChiLTERN will allow us to move towards an era of personalised therapy in which each patient will receive the correct amount of chemotherapy and will undergo has the best surgical operation (surgical resection or liver transplant). By using both clinical and biological information, we can assign patients more accurately to risk groups based on their survival. Using genetic tests and biomarkers, we will determine those children who may be at risk of developing long term side effects (deafness, heart failure, kidney damage). In addition, biomarkers will allow us to monitor during therapy and detect toxicities early before serious damage is done so that we can adapt treatment and prevent these problems. Finally, we will be using imaging technology tools which will help our surgeons plan liver operations more safely and effectively. Ultimately ChiLTERN will allow us to cure more children with liver cancer, expose fewer children to toxic chemotherapy and ensure their surgery is both effective and safe.

Dziedzina nauki

Program(-y)

Temat(-y)

Zaproszenie do składania wniosków

H2020-PHC-2014-2015

Zobacz inne projekty w ramach tego zaproszenia

Szczegółowe działanie

H2020-PHC-2015-two-stage

System finansowania

RIA - Research and Innovation action

Koordynator

THE UNIVERSITY OF BIRMINGHAM
Wkład UE netto
€ 2 676 440,35
Adres
Edgbaston
B15 2TT Birmingham
Zjednoczone Królestwo

Zobacz na mapie
Region
West Midlands (England) West Midlands Birmingham
Rodzaj działalności
Higher or Secondary Education Establishments
Linki
Koszt całkowity
€ 2 676 440,35

Uczestnicy (29)

Udostępnij tę stronę

Pobierz

Ostatnia aktualizacja: 17 Stycznia 2023

Moja broszura

Permalink: https://cordis.europa.eu/project/id/668596/pl

European Union, 2024